loadpatents
name:-0.46040797233582
name:-0.02251410484314
name:-0.0014841556549072
Langham; Barry John Patent Filings

Langham; Barry John

Patent Applications and Registrations

Patent applications and USPTO patent grants for Langham; Barry John.The latest application filed is for "quinoline and quinoxaline derivatives as kinase inhibitors".

Company Profile
1.22.27
  • Langham; Barry John - Slough GB
  • Langham; Barry John - Slough Berkshire GB
  • Langham; Barry John - Berkshire GB
  • Langham; Barry John - Reading GB
  • Langham; Barry John - Reading Berkshire GB
*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.
Patent Activity
PatentDate
Quinoline derivatives as kinase inhibitors
Grant 9,029,392 - Parton , et al. May 12, 2
2015-05-12
Thieno-pyridine derivatives as MEK inhibitors
Grant 8,637,491 - Johnson , et al. January 28, 2
2014-01-28
Thieno-pyridine derivatives as MEK inhibitors
Grant 8,604,051 - Hutchings , et al. December 10, 2
2013-12-10
Quinoline and Quinoxaline Derivatives as Kinase Inhibitors
App 20130296338 - Parton; Andrew Harry ;   et al.
2013-11-07
Thieno-pyridine derivatives as MEK inhibitors
Grant 8,487,101 - Brookings , et al. July 16, 2
2013-07-16
Thieno-pyridine Derivatives As Mek Inhibitors
App 20130150573 - Hutchings; Clive Martin ;   et al.
2013-06-13
Thieno-pyridine derivatives as MEK inhibitors
Grant 8,394,822 - Hutchings , et al. March 12, 2
2013-03-12
Thieno-pyridine derivatives as MEK inhibitors
Grant 8,350,037 - Johnson , et al. January 8, 2
2013-01-08
Thieno-pyridine Derivatives As Mek Inhibitors
App 20120329774 - Hutchings; Clive Martin ;   et al.
2012-12-27
Thieno-pyridine derivatives as MEK inhibitors
Grant 8,283,359 - Hutchings , et al. October 9, 2
2012-10-09
Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
App 20120095005 - Allen; Daniel Rees ;   et al.
2012-04-19
Thieno-pyridine Derivatives As Mek Inhibitors
App 20110172191 - Johnson; James Andrew ;   et al.
2011-07-14
Thieno-pyridine Derivatives As Mek Inhibitors
App 20110021558 - Brookings; Daniel Christopher ;   et al.
2011-01-27
Bicyclic heteroaromatic derivatives
Grant 7,763,729 - Brookings , et al. July 27, 2
2010-07-27
Novel Aminothienopyridinone Derivatives Processes for Preparing Them and Pharmaceutical Compositions Thereof
App 20100179185 - Davis; Jeremy Martin ;   et al.
2010-07-15
Thieno-pyridine Derivatives As Mek Inhibitors
App 20100179124 - Johnson; James Andrew ;   et al.
2010-07-15
Fused Thiophene Derivatives As Mek Inhibitors
App 20090264411 - Laing; Victoria Elizabeth ;   et al.
2009-10-22
Bicyclic heteroaromatic compounds as kinase inhibitors
Grant 7,592,455 - Brookings , et al. September 22, 2
2009-09-22
Thieno-pyridine Derivatives As Mek Inhibitors
App 20090149437 - Hutchings; Clive Martin ;   et al.
2009-06-11
Thienopyridone derivatives as kinase inhibitors
Grant 7,521,460 - Brookings , et al. April 21, 2
2009-04-21
Bicyclic Heteroaromatic Derivatives
App 20090042877 - Brookings; Daniel Christopher ;   et al.
2009-02-12
Bicyclic heteroaromatic compounds as kinase inhibitors
Grant 7,456,286 - Brookings , et al. November 25, 2
2008-11-25
Arylamine substituted bicyclic heteroaromatic compounds as p38 kinase inhibitors
Grant 7,423,047 - Brookings , et al. September 9, 2
2008-09-09
Pyridine and pyrimidine derivatives
Grant 7,323,464 - Davis , et al. January 29, 2
2008-01-29
Thienopyridone derivatives as kinase inhibitors
App 20070099894 - Langham; Barry John
2007-05-03
Bicyclic oxopyridine and oxopyrimidine derivatives
Grant 7,176,215 - Davis , et al. February 13, 2
2007-02-13
Thienopyridone derivatives as kinase inhibitors
App 20060247269 - Brookings; Daniel Christopher ;   et al.
2006-11-02
Bicyclic heteroaromatic compounds as kinase inhibitors
App 20060122212 - Brookings; Daniel Christopher ;   et al.
2006-06-08
Bicyclic heteroaromatic compounds as kinase inhibitors
App 20060025428 - Brookings; Daniel Christopher ;   et al.
2006-02-02
Arylamine substututed bicyclic heteroaromatic compounds as p38 kinase inhibitors
App 20060004025 - Brookings; Daniel Christopher ;   et al.
2006-01-05
Pyridine and pyrimidine derivatives
App 20050080258 - Davis, Jeremy Martin ;   et al.
2005-04-14
Bicyclic oxopyridine and oxopyrimidine derivatives
App 20040254200 - Davis, Jeremy Martin ;   et al.
2004-12-16
Enamine derivatives
Grant 6,780,874 - Norman , et al. August 24, 2
2004-08-24
Squaric acid derivatives
Grant 6,740,654 - Langham , et al. May 25, 2
2004-05-25
Enamine Derivatives
App 20030229116 - Norman, Timothy John ;   et al.
2003-12-11
Squaric acid derivatives
App 20030162799 - Langham, Barry John ;   et al.
2003-08-28
Enamine derivatives
Grant 6,610,700 - Norman , et al. August 26, 2
2003-08-26
Squaric acid derivatives
Grant 6,518,283 - Langham , et al. February 11, 2
2003-02-11
Squaric acid derivates
Grant 6,455,539 - Langham , et al. September 24, 2
2002-09-24
2, 7-naphthyridine derivatives
App 20020115684 - Langham, Barry John ;   et al.
2002-08-22
Squaric acid derivatives
App 20020107263 - Langham, Barry John ;   et al.
2002-08-08
Propanoic acid derivatives as integrin inhibitors
App 20020099210 - Alexander, Rikki Peter ;   et al.
2002-07-25
Enamine derivatives
App 20020037909 - Norman, Timothy John ;   et al.
2002-03-28
Propanoic acid derivatives
App 20020035092 - Alexander, Rikki Peter ;   et al.
2002-03-21
Squaric acid derivatives
App 20010020017 - Langham, Barry John ;   et al.
2001-09-06

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed